Objective: The study explored the change in handwritten signature in neurodegenerative diseases by using of a rater-based approach. Methods: Four independent observers were required to compare a pair of signatures (on average, 5 years elapsed between the two signatures) made by 103 patients (mean age 72 years) with Alzheimer's disease (AD) or frontotemporal dementia (FTD) and by 31 healthy participants (HC; mean age 73 years), judging their change according to a 0-1 rating scale (0 = similar or 1 = different). If a signature change was detected, the rater had also to report which signature features (spatial layout, omitted/added/switched letters or names, shape of letter, pen-flow) changed on the same 0-1 scale. For the AD and FTD groups, one signature was collected prior to the diagnosis of dementia, the other subsequent. Results: A signature change was reported by raters in 36% of AD patients, 44% of FTD, and 17% of HC, with significant differences between both clinical groups and HC (vs. AD, p = .01; vs. FTD, p = .001). There was not a distinctive marker of the signature change (i.e., feature change) in patients with dementia. Moreover, the signature changes in neurological patients were unrelated to their clinical and demographic characteristics (age, sex, education, time elapsed between the two signatures, Mini-mental State Examination score). Conclusion: The findings suggest a resistance of handwritten signature in neurodegenerative diseases and in physiological aging, also suggesting that the signature may be an unreliable indicator of the cognitive status in AD and FTD, at least if subjectively evaluated.

Does cognitive decline influence signing? / Preti, Alice Naomi; Diana, Lorenzo; Castaldo, Rita; Pischedda, Francesca; Difonzo, Teresa; Fumagalli, Giorgio; Arighi, Andrea; Sartori, Giuseppe; Zago, Stefano; Bolognini, Nadia. - In: AGING CLINICAL AND EXPERIMENTAL RESEARCH. - ISSN 1720-8319. - 2023, 35:(2023), pp. 2685-2691. [10.1007/s40520-023-02523-7]

Does cognitive decline influence signing?

Fumagalli, Giorgio;
2023-01-01

Abstract

Objective: The study explored the change in handwritten signature in neurodegenerative diseases by using of a rater-based approach. Methods: Four independent observers were required to compare a pair of signatures (on average, 5 years elapsed between the two signatures) made by 103 patients (mean age 72 years) with Alzheimer's disease (AD) or frontotemporal dementia (FTD) and by 31 healthy participants (HC; mean age 73 years), judging their change according to a 0-1 rating scale (0 = similar or 1 = different). If a signature change was detected, the rater had also to report which signature features (spatial layout, omitted/added/switched letters or names, shape of letter, pen-flow) changed on the same 0-1 scale. For the AD and FTD groups, one signature was collected prior to the diagnosis of dementia, the other subsequent. Results: A signature change was reported by raters in 36% of AD patients, 44% of FTD, and 17% of HC, with significant differences between both clinical groups and HC (vs. AD, p = .01; vs. FTD, p = .001). There was not a distinctive marker of the signature change (i.e., feature change) in patients with dementia. Moreover, the signature changes in neurological patients were unrelated to their clinical and demographic characteristics (age, sex, education, time elapsed between the two signatures, Mini-mental State Examination score). Conclusion: The findings suggest a resistance of handwritten signature in neurodegenerative diseases and in physiological aging, also suggesting that the signature may be an unreliable indicator of the cognitive status in AD and FTD, at least if subjectively evaluated.
2023
Preti, Alice Naomi; Diana, Lorenzo; Castaldo, Rita; Pischedda, Francesca; Difonzo, Teresa; Fumagalli, Giorgio; Arighi, Andrea; Sartori, Giuseppe; Zago, Stefano; Bolognini, Nadia
Does cognitive decline influence signing? / Preti, Alice Naomi; Diana, Lorenzo; Castaldo, Rita; Pischedda, Francesca; Difonzo, Teresa; Fumagalli, Giorgio; Arighi, Andrea; Sartori, Giuseppe; Zago, Stefano; Bolognini, Nadia. - In: AGING CLINICAL AND EXPERIMENTAL RESEARCH. - ISSN 1720-8319. - 2023, 35:(2023), pp. 2685-2691. [10.1007/s40520-023-02523-7]
File in questo prodotto:
File Dimensione Formato  
2023 Preti et al signature.pdf

accesso aperto

Tipologia: Versione editoriale (Publisher’s layout)
Licenza: Creative commons
Dimensione 720.9 kB
Formato Adobe PDF
720.9 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11572/393731
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact